Target intelligence / Profile preview

Peptidylprolyl isomerase A pseudogene 72 (PPIAP72)

Target
PPIAP72
Molecular classification
Pseudogene, long non-coding RNA (lncRNA)
01

Overview

Peptidylprolyl isomerase A pseudogene 72 (PPIAP72) is a non-functional genomic sequence in humans that shares significant sequence homology with the protein-coding gene peptidylprolyl isomerase A (PPIA)[1][2]. Unlike the functional PPIA gene, which encodes cyclophilin A—an enzyme involved in protein folding, immune response, and disease pathology—PPIAP72 is classified as a pseudogene and does not encode any protein or functional receptor[1][2][4]. Pseudogenes like PPIAP72 may sometimes be transcribed into RNA and can play regulatory roles at the RNA level, such as sponging microRNAs or participating in chromatin architecture, but PPIAP72 itself is not involved in canonical molecular target activities (enzyme, receptor, transporter)[5][6][8]. There are no known direct therapeutic, biomarker, or drug interaction roles attributed to PPIAP72 specifically.

Other names
Peptidylprolyl isomerase A pseudogene 72PPIAP72
02

Biological functions

Possible roles in gene expression regulation as a non-coding RNA (inferred from related pseudogenes of the same family, e.g., PPIAP22)may act as a competing endogenous RNA (ceRNA)sponge for microRNAsparticipate in epigenetic regulation of parental gene expression
03

Disease associations

No direct disease associations knownrelated pseudogenes (such as PPIAP22) have roles in cancer, especially hepatocellular carcinoma, through regulation of immune infiltration and tumor cell proliferation

Beyond the preview

Go deeper on Peptidylprolyl isomerase A pseudogene 72 (PPIAP72).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 72 (PPIAP72).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call